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May 20111448 AbstractsEarly Outcomes of Deliberate Nonoperative Management for Blunt
Thoracic Aortic Injury in Trauma
Caffarelli AD, Mallidi HR, Maggio PM, et al. J Thorac Cardiovasc Surg
2010;140:598-605.
Conclusion: Nonoperative management of carefully selected patients
with blunt thoracic aortic injury is safe in the short-term, but serial imaging
and long-term follow-up are necessary.
Summary: Early operative repair has been standard management of
blunt thoracic aortic injuries, and delayed repair has also become accepted in
recent years. In this article, the authors go a step further and report
deliberate nonoperative management of blunt thoracic aortic injury. Over
the last decade, with improved prehospital care and imaging, a spectrum of
thoracic aortic injuries can be identified. Whereas, it has now become
common to treat blunt thoracic aortic injury with thoracic endovascular
aneurysm repair, the authors have expressed reluctance to implant en-
dografts in young patients with perhaps 5 or 6 decades more years of life
expectancy. They have therefore adopted a deliberate strategy of nonopera-
tive management of selected patients with blunt thoracic aortic injury. This
strategy includes aggressive negative inotropic therapy, serial imaging, and
close clinical observation. This report presents their results of deliberate
nonoperative management of blunt thoracic aortic injury. This was a retro-
spective record review. The patients treated with nonoperative management
for blunt thoracic aortic injury were analyzed for survival, evolution of aortic
injury, and treatment failure. There were 53 patients (average age, 45 years)
who presented to Stanford University School of Medicine Emergency
Department with blunt thoracic aortic injury. Nearly three-quarters of these
patients were transferred from other hospitals. Twenty-nine of 53 patients
underwent planned nonoperative management of their blunt thoracic aortic
injury. In-hospital survival for these 29 patients was 93%. No death was
secondary to an aortic injury. At a median of 1.8 years (range, 0.9-7.2 years)
survival was 97%. Nonoperative management failed in one patient, who
underwent open repair. Serial imaging was performed in all patients (aver-
age, 107 days; median, 31 days). Stable aortic injuries without progression
were noted in 21 patients, and 5 had resolution of their aortic injury. Eight
patients were lost to follow-up. All patients had Social Security Numbers,
and none were listed in the Social Security Death Index and, therefore, are
presumed alive.
Comment: Another so-called principle of trauma management has
now come under question. Fifteen years ago, anyone advocating delayed
and, now even nonoperative, management of thoracic aortic injury would
have been hooted out of the room. The Stanford surgeons are to be
congratulated for their continued contributions to the management of
thoracic aortic disease and their willingness to look at the patients in their
practice, and based on these observations, to then buck the current trend to
reflexively treat thoracic aortic injuries with endovascular repair. Of course
this is one practice where almost 75% of the patients with thoracic injury
were received as transfers, and the patients are “selectively” managed.
However, this is also likely the case in most centers that treat thoracic aortic
injuries, and one can strongly suspect that the author’s observations will be
transferable to other centers as well.
Long-Term Results of Endoscopic Versus Open Saphenous Vein Har-
vest for Lower Extremity Bypass
Julliard W, Katzen J, Nebozny M, et al. Ann Vasc Surg 2011;25:101-7.
Conclusion: For lower extremity bypass, there is inferior long-term
patency of the bypass when great saphenous veins (GSV) are harvested with
endoscopic techniques vs open techniques.
Summary: For lower extremity bypass surgery GSVs are traditionally
harvested with open visualization of the vein. Early series of endoscopic
harvest demonstrated similar lower extremity bypass patency, with decreased
wound complications in patients operated on with endoscopic vs open vein
harvest (Jordan WD, et. al; J Vas Surg 2001;34:434-9; Illig KA, et al; Ann
Vasc Surg 2001;15:104-9). A more recent series, however, found decreased
graft patency after endoscopic harvest, without improvement in wound
complications in patients undergoing lower extremity bypass (Pullat R, et al;
J Vasc Surg 2006;44:289-95). In a recently reported large series of patients
undergoing coronary artery bypass grafting, there was decreased graft pa-
tency as well as decreased survival rates with endoscopic vs open harvest of
the GSV (Lopes RD, et al; N Engl J Med 2009;361:235-44). On the basis
of these more recent series, the authors analyzed their results of lower
extremity vein bypass over 8.5 years with endoscopic vs open vein harvest. Of
the 363 patients in the series (average age, 67  24), 170 underwent
endoscopic vein harvest, and 90% of the endoscopic procedures were per-
formed using a non-insufflation technique with clips rather than cautery to
obtain hemostasis of the side branches. Open harvest of the GSV by
continuous or skipped incisions was used in 193 patients. Tissue loss was
present in 48% of the patients, and there were no differences in indications
for surgery between the patients undergoing endoscopic vs open harvest of
the GSV. Median follow-up was 35.1 months (range, 1-105 months).
Primary patency rates were worse in the endoscopic vein harvest group
compared with the conventional harvest group at 6 months (63.3% 4% vs
U
T7.3%  3%), at 12 months (50.4%  4.2% vs 73.7%  3.6%), and at 36
onths (42.2% 4.5% vs 59.1% 4.9%; P .001 for all). Limb salvage and
urvival were identical. There were no differences in wound complications or
engths of stay between patients undergoing endoscopic vs open GSV
arvest.
Comment: The results of the study show overall inferior long-term
atency for endoscopic harvested GSVs used in lower extremity bypass.
hese authors were among the first to report potential benefit of endoscopic
arvested veins for lower extremity bypass. There are to be congratulated for
he courage to report updated results that conflict with their earlier obser-
ations. The results of the current study may be due to many factors. The
uthors sometimes use endoscopic techniques below the knee, and this may
ead to inferior results. In addition, preoperative vein mapping with marking
he course of the GSV on the skin may result in decreased wound compli-
ations by less undermining of flaps in the current compared with earlier
eries. The authors found little difference in patency between endoscopic
nd open harvest in patients treated for claudication and in nondiabetic
atients. Therefore, there may be reason not to completely abandon endo-
copic harvest but rather to restrict the technique to nondiabetic patients
reated for claudication and to limit endoscopic harvest to the above knee
SV.
reoperative Angiography and Transarterial Embolization in the Man-
gement of Carotid Body Tumor: A Single-Center, 10-year Experience
i J, Wang S, Zee C, et al. Neurosurgery 2010;67:941-948.
Conclusion: Preoperative embolization of carotid body tumors
CBTs) is safe and effective to facilitate surgical resection.
Summary: Larger CBTs, classified as Shamblin class II (those that
artially surround the internal and external carotid arteries) and Shamblin
lass III (those that completely surround the carotid bifurcation and/or the
nternal carotid artery) can be difficult to remove, and excessive blood loss is
ossible. Some surgeons therefore advocate preoperative embolization of
arger, Shamblin class II and III CBTs. Others believe preoperative embo-
ization is unnecessary and has the added risk of neurologic complication.
he authors present a series of 62 patients with Shamblin class II or III
umors that were operated on during a 10-year period in their institution.
hey divided the patients into two groups. The first group (group I) had
reoperative embolization and included 33 patients with 11 class II and 25
lass III lesions. Group II had surgery without preoperative embolization
nd included 29 patients with 9 class II lesions, and 21 class III lesions. The
wo groups were compared with respect to mean intraoperative blood loss,
peration time, postoperative hospital stay, and clinical complications. The
uthors felt that angiography after embolization demonstrated complete
BT devascularization in 76% of the lesions and partial devascularization in
4%.Mean intraoperative blood loss was 354 334mL in group I vs 656
98 mL in group II (P  .008). The mean operation time was 170  75
inutes in group I vs 224  114 minutes in group II (P  .034). Hospital
tay was prolonged in both groups, but was still less in group I (8.0 2 days)
han group II (9.5  3.5 days; P  .042). Transient ischemic attacks
ccurred in 10.3% of patients in group II vs in 3% of patients in group I.
ranial nerve injuries occurred in 13.8% of patients in group II and were not
bserved in group I.
Comment: This is the largest published series of CBTs operated on
ith preoperative embolization. Apparently, although not specifically men-
ioned, there were no significant complications associated with the preoper-
tive embolization, and the procedure was successful most of the time. It is
nclear how the patients were allocated to group I or group II, with
llocation likely on the basis of surgeon preference. It is also unclear whether
nclusion into group I or group II changed over time and whether the same
roportion were operated by the same surgeons in group I and group II.
herefore, the benefits of preoperative embolization in terms of operative
ime and blood loss, although potentially ascribed to the procedure, may
lso be surgeon-specific. Nevertheless, it does appear that preoperative
mbolization of larger CBTs can be done with technical success andminimal
omplications.
rognostic Significance of Deep Vein Thrombosis in Patients Present-
ng with Acute Symptomatic Pulmonary Embolism
imezez D, Aujesky D, Diaz G, and the RIETE Investigators. Am J Respir
rit Care Med 2010;181:983-91.
Conclusion: In patients with an acute symptomatic pulmonary embo-
ism (PE), a concurrent diagnosis of deep venous thrombosis (DVT) is an
ndependent predictor of increased risk of death within 3 months after the
E diagnosis.
Summary: The 3-month mortality rates after an objectively confirmed
iagnosis of acute PE vary from 1.4% to 17.4%. Variability in mortality likely
llustrates differences in the clinical spectrum of patients with PE. Early
eaths in patients with PE are secondary to PE-associated complications.
nderlying medical problems cause most late deaths (Conget F, et al;
hromb Haemost 2008;100:937-42). Up to 61% of patients with acute PE
